ArticleBMC psychiatry2026
Digital biomarkers in the diagnosis of social anxiety disorder: a scoping review.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSocial anxiety disorder (SAD) is a common but often overlooked mental disorder. Its traditional diagnosis combines the assessment of cognitive symptoms with the evaluation of emotional and behavioral patterns. With the widespread use of smart phones and wearable devices, digital biomarkers available through these devices have provided a new objective quantitative method for mental health diagnosis.
objectiveThe aim of this study was to investigate the application of digital biomarkers in the diagnosis of social anxiety disorder.
methodsBased on the methodological framework of Arksey and O’Malley, we conducted a review using multiple databases such as PubMed, Web of Science, EMbase, Scopus and ACM Digital Library. From the establishment of each database to August 2025, any original research in the research design will focus on this topic and be published in English, using the following search strategy: (“social phobia” OR “Social Anxiety” OR “Social Anxiety Disorder”) AND (“Smartphone Sensor” OR “digital phenotyping” OR “digital phenotype” OR “digital biomarker” OR “mobile sensing” OR “passive sensing” OR “Wearable devices” OR “APP” OR “Electronic health records” OR “Electronic Medical Record”).
resultsWe identified a total of 1586 studies in the database and ultimately included 15 of them. The literature mainly focuses on digital biomarkers in digital devices, and all studies have reported a positive association between these biomarkers and the prediction of social anxiety disorders.
conclusionAlthough various digital biomarkers such as physiological indicators, behavioral patterns, and language features have shown good value in assisting the early screening and objective monitoring of social anxiety disorders, their overall development is still in its infancy and has not yet formed diagnostic tools with sufficient clinical effectiveness. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.